Gigantism due to growth hormone excess in a boy with optic glioma

Clinical Endocrinology

Volumn 53, Issue 4, 2000, Pages 535-538

  Drimmie, F M ^a,c   Maclennan, A C ^a   Nicoll, J A R ^b   Simpson, E ^a   McNeill, E ^a   Donaldson, M D C ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN DERIVATIVE; GOSERELIN; GROWTH HORMONE; OCTREOTIDE; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE;

ARTICLE; CASE REPORT; CHILD; GIGANTISM; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONE DETERMINATION; HUMAN; HYPOPHYSIS ADENOMA; MALE; NEUROFIBROMATOSIS; OPTIC NERVE GLIOMA; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; SOMATOSTATIN RELEASE; TALL STATURE; VISUAL IMPAIRMENT;

ADULT; CHILD, PRESCHOOL; GIGANTISM; GONADOTROPIN-RELEASING HORMONE; GOSERELIN; GROWTH HORMONE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROFIBROMATOSIS 1; OCTREOTIDE; OPTIC NERVE GLIOMA; PUBERTY, PRECOCIOUS; SOMATOSTATIN;

EID: 0033789069     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.01041.x     Document Type: Article

References (8)

1. Endocrine disorders associated with tumors of the pituitary and hypothalamus
2. Hypothalamic gigantism
3. Optic gliomata affecting twins with neurofibromatosis
4. Hypothalamic mass and gigantism in neurofibromatosis: Treatment with bromocriptine
5. Growth hormone excess in a child with neurofibromatosis type 1 and optic pathway tumour: A patient report
6. Precocious puberty in children with neurofibromatosis type 1
7. Optic pathway glioma infiltrating into somatostatinergic pathways in a young boy with gigantism